Jeffrey H. Kordower - Related publications

Rush University, Chicago, IL, United States 
Neuroscience Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Tan Y, Ke M, Huang Z, Chong CM, Cen X, Lu JH, Yao X, Qin D, Su H. Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease. Aging and Disease. 10: 1037-1048. PMID 31595201 DOI: 10.14336/AD.2018.1216   
2019 Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease. Neurotoxicity Research. PMID 31478124 DOI: 10.1007/s12640-019-00104-z   
2019 Shams R, Banik NL, Haque A. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease. Progress in Molecular Biology and Translational Science. 167: 107-124. PMID 31601400 DOI: 10.1016/bs.pmbts.2019.06.007   
2019 Wong YC, Luk K, Purtell K, Burke Nanni S, Stoessl AJ, Trudeau LE, Yue Z, Krainc D, Oertel W, Obeso JA, Volpicelli-Daley LA. Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31483900 DOI: 10.1002/mds.27823   
2019 Ghaisas S, Langley MR, Palanisamy BN, Dutta S, Narayanaswamy K, Plummer PJ, Sarkar S, Ay M, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. MitoPark Transgenic Mouse Model Recapitulates the Gastrointestinal Dysfunction and Gut-Microbiome Changes of Parkinson's Disease. Neurotoxicology. PMID 31505196 DOI: 10.1016/j.neuro.2019.09.004   
2019 Larijani B, Goodarzi P, Payab M, Tayanloo-Beik A, Sarvari M, Gholami M, Gilany K, Nasli-Esfahani E, Yarahmadi M, Ghaderi F, Arjmand B. The Design and Application of an Appropriate Parkinson's Disease Animal Model in Regenerative Medicine. Advances in Experimental Medicine and Biology. PMID 31485993 DOI: 10.1007/5584_2019_422   
2019 Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G, Marino G, Calabrese V, Vedele F, Ghiglieri V, Picconi B, Di Lazzaro G, Schirinzi T, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nature Communications. 10: 3945. PMID 31477726 DOI: 10.1038/s41467-019-11928-w   
2019 Mei M, Zhou Y, Liu M, Zhao F, Wang C, Ding J, Lu M, Hu G. Antioxidant and anti-inflammatory effects of Dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease. Neuropharmacology. 107758. PMID 31494143 DOI: 10.1016/j.neuropharm.2019.107758   
2019 Lee EH, Kim SM, Kim CH, Pagire SH, Pagire HS, Chung HY, Ahn JH, Park CH. Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives. Scientific Reports. 9: 13659. PMID 31541140 DOI: 10.1038/s41598-019-49876-6   
2019 Ke M, Chong CM, Su H. Using induced pluripotent stem cells for modeling Parkinson's disease. World Journal of Stem Cells. 11: 634-649. PMID 31616540 DOI: 10.4252/wjsc.v11.i9.634   
2019 Espinoza S, Scarpato M, Damiani D, Managò F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31495777 DOI: 10.1016/j.ymthe.2019.08.005   
2019 Ardashov OV, Pavlova AV, Mahato AK, Sidorova Y, Morozova EA, Korchagina DV, Salnikov GE, Genaev AM, Patrusheva OS, Li-Zhulanov NS, Tolstikova TG, Volcho KP, Salakhutdinov NF. A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson's Disease. Acs Chemical Neuroscience. PMID 31464415 DOI: 10.1021/acschemneuro.9b00396   
2019 Giuliano C, Siani F, Mus L, Ghezzi C, Cerri S, Pacchetti B, Bigogno C, Blandini F. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease. Nutrition (Burbank, Los Angeles County, Calif.). 69: 110494. PMID 31586482 DOI: 10.1016/j.nut.2019.04.006   
2019 Yu Y, Lang XY, Li XX, Gu RZ, Liu QS, Lan R, Qin XY. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis. Food & Function. PMID 31482900 DOI: 10.1039/c9fo01309a   
2019 Kim DH, Choi JJ, Park BJ. Herbal medicine (Hepad) prevents dopaminergic neuronal death in the rat MPTP model of Parkinson's disease. Integrative Medicine Research. 8: 202-208. PMID 31467840 DOI: 10.1016/j.imr.2019.07.005   
2019 Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB, Ho SL. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease. Translational Neurodegeneration. 8: 23. PMID 31428316 DOI: 10.1186/s40035-019-0165-9   
2019 Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell. e13031. PMID 31432604 DOI: 10.1111/acel.13031   
2019 Kandil EA, Sayed RH, Ahmed LA, Abd El Fattah MA, El-Sayeh BM. Hypoxia-inducible factor 1 alpha and nuclear related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease. Clinical and Experimental Pharmacology & Physiology. PMID 31408200 DOI: 10.1111/1440-1681.13162   
2019 Maulik M, Mitra S, Basmayor AM, Lu B, Taylor BE, Bult-Ito A. Genetic Silencing of Fatty Acid Desaturases Modulates α-Synuclein Toxicity and Neuronal Loss in Parkinson-Like Models of . Frontiers in Aging Neuroscience. 11: 207. PMID 31447665 DOI: 10.3389/fnagi.2019.00207   
2019 Sharma S, Awasthi A, Singh S. Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management. Neuroscience Letters. 134516. PMID 31560998 DOI: 10.1016/j.neulet.2019.134516   
2019 Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, et al. Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases. The Journal of Clinical Investigation. PMID 31524631 DOI: 10.1172/JCI129987   
2019 Foffani G, Trigo-Damas I, Pineda-Pardo JA, Blesa J, Rodríguez-Rojas R, Martínez-Fernández R, Obeso JA. Focused ultrasound in Parkinson's disease: A twofold path toward disease modification. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31412430 DOI: 10.1002/mds.27805   
2019 Chen QQ, Haikal C, Li W, Li JY. Gut Inflammation in Association With Pathogenesis of Parkinson's Disease. Frontiers in Molecular Neuroscience. 12: 218. PMID 31572126 DOI: 10.3389/fnmol.2019.00218   
2019 Jiang X, Jin T, Zhang H, Miao J, Zhao X, Su Y, Zhang Y. Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease. Oxidative Medicine and Cellular Longevity. 2019: 4578462. PMID 31485291 DOI: 10.1155/2019/4578462   
2019 Mercado G, Brundin P. Lots of Movement in Gut and Parkinson's Research. Trends in Endocrinology and Metabolism: Tem. PMID 31473011 DOI: 10.1016/j.tem.2019.08.001   
2019 Keane PC, Hanson PS, Patterson L, Blain PG, Hepplewhite P, Khundakar AA, Judge SJ, Kahle P, LeBeau FEN, Morris CM. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice. Neuroscience Letters. 134437. PMID 31422098 DOI: 10.1016/j.neulet.2019.134437   
2019 Han J, Kim SJ, Ryu MJ, Jang Y, Lee MJ, Ju X, Lee YL, Cui J, Shong M, Heo JY, Kweon GR. Chloramphenicol Mitigates Oxidative Stress by Inhibiting Translation of Mitochondrial Complex I in Dopaminergic Neurons of Toxin-Induced Parkinson's Disease Model. Oxidative Medicine and Cellular Longevity. 2019: 4174803. PMID 31534621 DOI: 10.1155/2019/4174803   
2019 Nadeau J, Smith T, Lamontagne-Proulx J, Bourque M, Al Sweidi S, Jayasinghe D, Ritchie S, Di Paolo T, Soulet D. Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor. Brain Research. 1725: 146460. PMID 31525350 DOI: 10.1016/j.brainres.2019.146460   
2019 Liu CT, Kao LT, Shih JH, Chien WC, Chiu CH, Ma KH, Huang YS, Cheng CY, Shiue CY, Li IH. The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study. European Journal of Pharmacology. 172639. PMID 31491406 DOI: 10.1016/j.ejphar.2019.172639   
2019 Af Bjerkén S, Stenmark Persson R, Barkander A, Karalija N, Pelegrina-Hidalgo N, Gerhardt GA, Virel A, Strömberg I. Noradrenaline is crucial for the substantia nigra dopaminergic cell maintenance. Neurochemistry International. 131: 104551. PMID 31542295 DOI: 10.1016/j.neuint.2019.104551   
2019 Arotcarena ML, Bourdenx M, Dutheil N, Thiolat ML, Doudnikoff E, Dovero S, Ballabio A, Fernagut PO, Meissner WG, Bezard E, Dehay B. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. Jci Insight. 4. PMID 31434803 DOI: 10.1172/jci.insight.129719   
2019 Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Tammie BLS, Morris JC, Xu J. The Interactions of Dopamine and Oxidative Damage in the Striatum of Neurodegenerative Diseases Patients. Journal of Neurochemistry. PMID 31613384 DOI: 10.1111/jnc.14898   
2019 Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Tammie BLS, Morris JC, Xu J. The Interactions of Dopamine and Oxidative Damage in the Striatum of Neurodegenerative Diseases Patients. Journal of Neurochemistry. PMID 31613384 DOI: 10.1111/jnc.14898   
2019 O'Neill E, Yssel JD, McNamara C, Harkin A. Pharmacological targeting of β -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease. British Journal of Pharmacology. PMID 31506926 DOI: 10.1111/bph.14862   
2019 Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Tellado I, Cacabelos N, Pego R, Carril JC. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease. Planta Medica. PMID 31559607 DOI: 10.1055/a-1013-7686   
2019 De Luca R, Latella D, Maggio MG, Di Lorenzo G, Maresca G, Sciarrone F, Militi D, Bramanti P, Calabrò RS. Computer assisted cognitive rehabilitation improves visuospatial and executive functions in Parkinson's disease: Preliminary results. Neurorehabilitation. PMID 31498141 DOI: 10.3233/NRE-192789   
2019 Jiang X, Tang PC, Chen Q, Zhang X, Fan YY, Yu BC, Gu XX, Sun Y, Ge XQ, Zhang XL. Neuroprotective effects of cordycepin with anti-apoptosis mechanism based on mitochondrial pathway in rotenone-induced parkinsonism rat model. Cns & Neurological Disorders Drug Targets. PMID 31486758 DOI: 10.2174/1871527318666190905152138   
2019 Kim T, Song S, Park Y, Kang S, Seo H. HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice. Experimental Neurobiology. 28: 504-515. PMID 31495079 DOI: 10.5607/en.2019.28.4.504   
2019 Balke D, Tatenhorst L, Dambeck V, Ribas VT, Vahsen BF, Michel U, Bähr M, Lingor P. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease. Molecular Neurobiology. PMID 31446549 DOI: 10.1007/s12035-019-01744-0   
2019 Yang Y, Qian J, Mei J, Zhong K, Niu C. detection of metabolic changes in the striatum of proteasomal inhibition-induced Parkinson's disease in rats using proton MR spectroscopy at 9.4 T. The International Journal of Neuroscience. 1-12. PMID 31516042 DOI: 10.1080/00207454.2019.1667783   
2019 Yang Y, Qian J, Mei J, Zhong K, Niu C. detection of metabolic changes in the striatum of proteasomal inhibition-induced Parkinson's disease in rats using proton MR spectroscopy at 9.4 T. The International Journal of Neuroscience. 1-12. PMID 31516042 DOI: 10.1080/00207454.2019.1667783   
2019 O'Brien JA, Austin PJ. Effect of Photobiomodulation in Rescuing Lipopolysaccharide-Induced Dopaminergic Cell Loss in the Male Sprague-Dawley Rat. Biomolecules. 9. PMID 31430990 DOI: 10.3390/biom9080381   
2019 Datta I, Mekha SR, Kaushal A, Ganapathy K, Razdan R. Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 31468077 DOI: 10.1007/s00210-019-01715-1   
2019 Kasanga EA, Owens CL, Cantu MA, Richard A, Davis RW, McDivitt LM, Blancher B, Pruett BS, Tan C, Gajewski A, Manfredsson FP, Nejtek VA, Salvatore MF. GFR-α1 expression in substantia nigra increases bilaterally following unilateral striatal GDNF in aged rats and attenuates nigral tyrosine hydroxylase loss following 6-OHDA nigrostriatal lesion. Acs Chemical Neuroscience. PMID 31538765 DOI: 10.1021/acschemneuro.9b00291   
2019 Jiménez-Sánchez L, Blesa J, Del Rey NL, Monje MH, Obeso JA, Cavada C. Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease. Neuropharmacology. 107806. PMID 31589886 DOI: 10.1016/j.neuropharm.2019.107806   
2019 Maitra U, Scaglione MN, Chtarbanova S, O'Donnell JM. Innate immune responses to paraquat exposure in a Drosophila model of Parkinson's disease. Scientific Reports. 9: 12714. PMID 31481676 DOI: 10.1038/s41598-019-48977-6   
2019 Lu J, Liu X, Tian Y, Li H, Ren Z, Liang S, Zhang G, Zhao C, Li X, Wang T, Chen D, Kuang W, Zhu M. Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson's Disease. Evidence-Based Complementary and Alternative Medicine : Ecam. 2019: 2735492. PMID 31467572 DOI: 10.1155/2019/2735492   
2019 Mou L, Ding W, Fernandez-Funez P. Open questions on the nature of Parkinson's disease: from triggers to spreading pathology. Journal of Medical Genetics. PMID 31484719 DOI: 10.1136/jmedgenet-2019-106210   
2019 Lu JQ, Fong C, Attar A. Levodopa-responsive parkinsonism in a patient with corticobasal degeneration and bilateral choroid plexus xanthogranulomas. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 31537463 DOI: 10.1016/j.jocn.2019.09.007   
2019 Sardoiwala MN, Srivastava AK, Kaundal B, Karmakar S, Choudhury SR. Recuperative effect of metformin loaded Polydopamine Nanoformulation promoting EZH2 mediated proteasomal degradation of phospho-α-Synuclein in Parkinson's disease model. Nanomedicine : Nanotechnology, Biology, and Medicine. 102088. PMID 31476446 DOI: 10.1016/j.nano.2019.102088